PNC Financial Services Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.55K | Buy |
|
|||||
|
2025
Q2 | $5.07K | Buy |
|
|||||
|
2025
Q1 | $2.06K | Buy |
|
|||||
|
2024
Q4 | $460 | Sell |
|
|||||
|
2024
Q3 | $3.31K | Hold |
|
|||||
|
2024
Q2 | $4.14K | Sell |
|
|||||
|
2024
Q1 | $37.6K | Buy |
|
|||||
|
2023
Q4 | $2.01K | Sell |
|
|||||
|
2023
Q3 | $11.7K | Sell |
|
|||||
|
2023
Q2 | $59.3K | Buy |
|
|||||
|
2023
Q1 | $45.4K | Buy |
|
|||||
|
2022
Q4 | $49K | Sell |
|
|||||
|
2022
Q3 | $55K | Buy |
|
|||||
|
2022
Q2 | $25K | Sell |
|
|||||
|
2022
Q1 | $80K | Buy |
|
|||||
|
2021
Q4 | $84K | Buy |
|
|||||
|
2021
Q3 | $55K | Sell |
|
|||||
|
2021
Q2 | $70K | Buy |
|
|||||
|
2021
Q1 | $39K | Buy |
|
|||||
|
2020
Q4 | $23K | Sell |
|
|||||
|
2020
Q3 | $49K | Buy |
|
|||||
|
2020
Q2 | $54K | Buy |
|
|||||
|
2020
Q1 | $56K | Buy |
|
|||||
|
2019
Q4 | $47K | Buy |
|
|||||
|
2019
Q3 | $44K | Sell |
|
|||||
|
2019
Q2 | $65K | Buy |
|
|||||
|
2019
Q1 | $71K | Buy |
|
|||||
|
2018
Q4 | $45K | Buy |
|
|||||
|
2018
Q3 | $33K | Buy |
|
|||||
|
2018
Q2 | $43K | Buy |
|
|||||
|
2018
Q1 | $22K | Buy |
|
|||||
|
2017
Q4 | $10K | Sell |
|
|||||
|
2017
Q3 | $8K | Sell |
|
|||||
|
2017
Q2 | $2.47M | Sell |
|
|||||
|
2017
Q1 | $2.12M | Sell |
|
|||||
|
2016
Q4 | $2.82M | Buy |
|
|||||
|
2016
Q3 | $391K | Buy |
|
|||||
|
2016
Q2 | $310K | Buy |
|
|||||
|
2016
Q1 | $263K | Buy |
|
|||||
|
2015
Q4 | $237K | Sell |
|
|||||
|
2015
Q3 | $477K | Sell |
|
|||||
|
2015
Q2 | $594K | Buy |
|
|||||
|
2015
Q1 | $4K | Sell |
|
|||||
|
2014
Q4 | $303K | Buy |
|
|||||
|
2014
Q3 | $170K | Sell |
|
|||||
|
2014
Q2 | $290K | Sell |
|
|||||
|
2014
Q1 | $280K | Buy |
|